GT Medical Technologies, Inc. completes acquisition of radioactive seed assets from Perspective Therapeutics, Inc.
GT Medical Technologies, Inc. completes acquisition of radioactive seed assets from Perspective Therapeutics, Inc.
04/15/24, 12:11 PM
Location
temperichlandIndustry
health care
medical
biotechnology
healthcare
The strategic acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc., solidifies GT MedTech's position as the sole manufacturer of Cesium-131 brachytherapy seeds for cancer treatments. This acquisition marks a significant investment for GT MedTech to vertically integrate the Cesium-131 manufacturing process, enhancing supply chain competencies and capabilities, and reinforcing the company's commitment to expand adoption of GammaTile® in the U.S.
Company Info
Location
1809 s holbrook lane, suite 107
Tempe, Arizona, United States
Company info
GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 1000+ patients with brain tumors.